Transforming Albumin into a Trojan Horse of Immunotherapy-Resistant Colorectal Cancer with a High Microsatellite Instability-Reference-Cited by-同舟云学术

Transforming Albumin into a Trojan Horse of Immunotherapy-Resistant Colorectal Cancer with a High Microsatellite Instability

Published:2024-07-11 Issue:29 Volume:18 Page:19332-19344
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Yang Wenguang¹,Li Zhanfeng¹,Li Yong²,He Wangxiao¹^ORCID,Yan Jin¹²³^ORCID

Affiliation:

1. Department of Medical Oncology and Department of Talent Highland, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, PR. China

2. National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, PR. China

3. Department of Infectious Diseases, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China

Funder

Xi?an Jiaotong University

National Key Research and Development Program of China

National Natural Science Foundation of China

Thousand Talents Plan of Shaanxi Province

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.4c05893

Reference37 articles.

1. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

2. FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors

3. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study

4. Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms

5. Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers